focus -WSS

focus

author：Wikipedia 2025-09-29 01:36:44 - browse：9692

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Awakening the world to the whoosh: A patient's crusade

hotspot

WSS

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Awakening the world to the whoosh: A patient's crusade

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

STAT Readout Newsletter: Biotech news today

I learned firsthand about improving diversity in clinical trials

focus

focus

knowledge

In age of alternative facts, a scholarly course on calling out crap

Tocagen's brain cancer gene therapy trial continues. Investors worry

Heart attack and stroke risk calculators need revising

ADCs take center stage as promising cancer treatments

Continuity nursing helped my family in our darkest PICU moments

Winning ticket for $1 billion Powerball jackpot sold in California

At least 13 dead in Texas as scorching temps continue

Tocagen's brain cancer gene therapy trial continues. Investors worry

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Summit: Meghan O’Rourke on making chronic illness visible

focus

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Stanford president faces new allegations over 1999 paper

Divers poised to search for children washed away in Pennsylvania flash flood

Smaller biotechs seek to piggyback on weight loss drug boom

Stanford president's case begs question: Who takes blame?

leisure time

hotspot

focus

leisure time